BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 11464029)

  • 1. Bladder cancer. II. Molecular aspects and diagnosis.
    Kausch I; Böhle A
    Eur Urol; 2001 May; 39(5):498-506. PubMed ID: 11464029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Non-invasive urinary diagnosis of bladder cancer. What do we know?].
    Kausch I; Böhle A
    Urologe A; 2003 Jul; 42(7):912-21. PubMed ID: 12898034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine cytology. It is still the gold standard for screening?
    Brown FM
    Urol Clin North Am; 2000 Feb; 27(1):25-37. PubMed ID: 10696242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current bladder tumor tests: does their projected utility fulfill clinical necessity?
    Lokeshwar VB; Soloway MS
    J Urol; 2001 Apr; 165(4):1067-77. PubMed ID: 11257640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary markers in the everyday diagnosis of bladder cancer.
    Dal Moro F; Valotto C; Guttilla A; Zattoni F
    Urologia; 2013; 80(4):265-75. PubMed ID: 24419920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine based markers of urological malignancy.
    Konety BR; Getzenberg RH
    J Urol; 2001 Feb; 165(2):600-11. PubMed ID: 11176445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replacing cystoscopy by urine markers in the follow-up of patients with low-risk non-muscle-invasive bladder cancer?-An International Bladder Cancer Network project.
    Schmitz-Dräger C; Bonberg N; Pesch B; Todenhöfer T; Sahin S; Behrens T; Brüning T; Schmitz-Dräger BJ
    Urol Oncol; 2016 Oct; 34(10):452-9. PubMed ID: 27381893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on urine-based markers for bladder cancer. How sensitive and specific are the new noninvasive tests?
    Pirtskalaishvili G; Konety BR; Getzenberg RH
    Postgrad Med; 1999 Nov; 106(6):85-6, 91-4. PubMed ID: 10576004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine-based biomarkers for the early detection and surveillance of non-muscle invasive bladder cancer.
    Herman MP; Svatek RS; Lotan Y; Karakiewizc PI; Shariat SF
    Minerva Urol Nefrol; 2008 Dec; 60(4):217-35. PubMed ID: 18923359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and emerging bladder cancer urinary biomarkers.
    Parker J; Spiess PE
    ScientificWorldJournal; 2011 May; 11():1103-12. PubMed ID: 21623456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of BTA stat Test in follow-up of patients with bladder cancer: results from FinnBladder studies.
    Raitanen MP;
    World J Urol; 2008 Feb; 26(1):45-50. PubMed ID: 18180926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study.
    Pfister C; Chautard D; Devonec M; Perrin P; Chopin D; Rischmann P; Bouchot O; Beurton D; Coulange C; Rambeaud JJ
    J Urol; 2003 Mar; 169(3):921-4. PubMed ID: 12576813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor markers in the diagnosis of primary bladder cancer. A systematic review.
    Glas AS; Roos D; Deutekom M; Zwinderman AH; Bossuyt PM; Kurth KH
    J Urol; 2003 Jun; 169(6):1975-82. PubMed ID: 12771702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive diagnostic tests for bladder cancer: a review of the literature.
    Bassi P; De Marco V; De Lisa A; Mancini M; Pinto F; Bertoloni R; Longo F
    Urol Int; 2005; 75(3):193-200. PubMed ID: 16215303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the nuclear matrix protein 22 with voided urine cytology and BTA stat test in the diagnosis of transitional cell carcinoma of the bladder.
    Sözen S; Biri H; Sinik Z; Küpeli B; Alkibay T; Bozkirli I
    Eur Urol; 1999 Sep; 36(3):225-9. PubMed ID: 10450007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of bladder tumours: role of cytology, morphology-based assays, biochemical and molecular markers.
    Eissa S; Kassim S; El-Ahmady O
    Curr Opin Obstet Gynecol; 2003 Oct; 15(5):395-403. PubMed ID: 14501243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.
    Blick CG; Nazir SA; Mallett S; Turney BW; Onwu NN; Roberts IS; Crew JP; Cowan NC
    BJU Int; 2012 Jul; 110(1):84-94. PubMed ID: 22122739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of urine-based markers for detection and monitoring of bladder cancer.
    Pirtskalaishvili G; Getzenberg RH; Konety BR
    Tech Urol; 1999 Dec; 5(4):179-84. PubMed ID: 10591254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary markers of bladder carcinoma.
    Dey P
    Clin Chim Acta; 2004 Feb; 340(1-2):57-65. PubMed ID: 14734196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer.
    Raitanen MP; Leppilahti M; Tuhkanen K; Forssel T; Nylund P; Tammela T;
    Ann Chir Gynaecol; 2001; 90(4):261-5. PubMed ID: 11820414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.